Ginseng-plus-Bai-Hu-Tang ameliorates diet-induced obesity, hepatic steatosis, and insulin resistance in mice
Open Access
- 27 October 2018
- journal article
- research article
- Published by Elsevier BV in Journal of Ginseng Research
- Vol. 44 (2), 238-246
- https://doi.org/10.1016/j.jgr.2018.10.005
Abstract
Background: Dietary fat has been suggested to be the cause of various health issues. Obesity, hypertension, cardiovascular disease, diabetes, dyslipidemia, and kidney disease are known to be associated with a high-fat diet (HFD). Obesity and associated conditions, such as type 2 diabetes mellitus and nonalcoholic fatty liver disease (NAFLD), are currently a worldwide health problem. Few prospective pharmaceutical therapies that directly target NAFLD are available at present. A Traditional Chinese Medicine, ginseng-plus-Bai-Hu-Tang (GBHT), is widely used by diabetic patients to control glucose level or thirst. However, whether it has therapeutic effects on fat-induced hepatic steatosis and metabolic syndrome remains unclear. Methods: This study was conducted to examine the therapeutic effect of GBHT on fat-induced obesity, hepatic steatosis, and insulin resistance in mice. Results: GBHT protected mice against HFD-induced body weight gain, hyperlipidemia, and hyperglycemia compared with mice that were not treated. GBHT inhibited the expansion of adipose tissue and adipocyte hypertrophy. No ectopic fat deposition was found in the livers of HFD mice treated with GBHT. In addition, glucose intolerance and insulin sensitivity in HFD mice was also improved by GBHT. Conclusion: GBHT prevents changes in lipid and carbohydrate metabolism in a HFD mouse model. Our findings provide evidence for the traditional use of GBHT as therapy for the management of metabolic syndrome.Keywords
Funding Information
- Ministry of Science and Technology, Taiwan (MOST104-2320-B-077-003, MOST 106-2320-B-077-006)
This publication has 38 references indexed in Scilit:
- High-fat feeding rapidly induces obesity and lipid derangements in C57BL/6N miceMammalian Genome, 2013
- Antiobesity and Antihyperglycemic Effects of Ginsenoside Rb1 in RatsDiabetes, 2010
- Antiobesity Effect of Eicosapentaenoic Acid in High-Fat/High-Sucrose Diet–Induced ObesityDiabetes, 2010
- Management of Hypertriglyceridemia in the Diabetic PatientCurrent Diabetes Reports, 2010
- Review: Treatment options for nonalcoholic fatty liver diseaseTherapeutic Advances in Gastroenterology, 2010
- Impaired Glucose Tolerance and Insulin Resistance Are Associated With Increased Adipose 11β-Hydroxysteroid Dehydrogenase Type 1 Expression and Elevated Hepatic 5α-Reductase ActivityDiabetes, 2008
- Suspected Nonalcoholic Fatty Liver Disease and Mortality Risk in a Population-Based Cohort StudyThe American Journal of Gastroenterology, 2008
- High-fat diets cause insulin resistance despite an increase in muscle mitochondriaProceedings of the National Academy of Sciences, 2008
- Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered miceJCI Insight, 2008
- Treatment of non-alcoholic fatty liver diseasePostgraduate Medical Journal, 2006